ProShares UltraPro Nasdaq Biotechnology UBIO · ETF Open ProShares UltraPro Nasdaq Biotechnology in new tab
Weights
Sector Weights
Country Weights
ProShares UltraPro Nasdaq Biotechnology Analysis (UBIO)
Investment Objective: ProShares UltraPro Nasdaq Biotechnology is an investment vehicle focused on the Financial Services sector . It is currently trading at 17.77 USD.
Portfolio Composition:
The fund is heavily weighted towards
the Healthcare sector (100%),
the Basic Materials sector (0%)
and markets in
Other (100%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This appears to be an accumulating fund (dividends are reinvested) or focuses purely on capital growth.
Investor FAQ
Does ProShares UltraPro Nasdaq Biotechnology pay a dividend?
No, it does not currently pay a dividend.
What asset class is ProShares UltraPro Nasdaq Biotechnology?
ProShares UltraPro Nasdaq Biotechnology is classified as a ETF.
Fund Strategy
The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the "index"). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
| Split Date | Split Ratio to 1 |
|---|---|
| Nov. 13, 2015 | 0.200000 |
Community Discussion